Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.87

-2.3%

Dec 5 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LLCF who wrote (338)	8/10/1999 12:17:00 AM
From: Micro-Selector	Read Replies (1) of 52153

Opinion on BSDM? Given recent news and current prospects certainly would be reasonable for it to finally make a move upward. Current situation: Price has hovered in $.30 - $.40 range over last 6 months while company awaited approval to sell new technology in European Union. Recently completed first shipments of new technology line (BSD-2000/3D) to Europe (backlog of orders was around $500K). This will be reflected on 4Q FY99 balance sheets. An additional $3M in litigation settlement should also be reflected on 4Q balance sheets. 20M shares authorized 16.5M shares out with approx 55% closely held 6M in float bsdmc.com biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next